Ulgix Flatulence (simethicone 80 mg)

Ulgix Flatulence (simethicone 80 mg)
Product Description

Type: Meducal device Pharmaceutical form: Capsules Package: 100, 50 capsules Active substance: 80 mg of Simethicone Properties and applications: Ulgix flatulence contains Simethicone which has the ability to lower the surface tension of the mucus and gas bubbles found in the intestine. In this manner, it facilitates removal of the gas accumulated in the gastrointestinal tract. Ulgix flatulence is used:

  • To relieve symptoms associated with accumulation of gas in the intestines, such as a feeling of fullness, flatulence, belching.
  • To remove the air and gas before performing diagnostic tests in the abdominal cavity with radiological, ultrasound and endoscopic techniques,.
Instructions for use: The product in the form of gelatin capsules is administered orally. Symptoms associated with accumulation of gas in the intestines: flatulence, feeling of fullness, belching: Adults: 1 capsule, 4 times per day. If necessary, the dose may be increased. The daily intake should not exceed 960 mg of Simethicone. Preparation for diagnostic examinations: The day before the examination: 1 capsule three times a day. The day of the examination: 1 capsule in the morning. The capsules should be administered after a meal with a sufficient amount of fluid (about 1 cup of water). If you miss a dose, do not administer a double dose to make up for the missed one. Do not exceed the recommended daily intake of the product. Do not use the product after its expiry date. brhrbrremoval of gasses gathered in intestine, against fullness in abdominal cavity

Hasco-Lek S.A.

  • PL
  • 2015
    On CPHI since
  • 2
    Certificates
  • 500 - 999
    Employees
Company types
Generics/Biosimilars Manufacturer
Licensee
Primary activities
Pharmaceutical Company (generic finished products)
Specifications
  • Selling Points
    Brand Name
  • Model
    soft gelatin capsule
  • Supplied from
    Poland
  • Measured In
    piece

Hasco-Lek S.A.

  • PL
  • 2015
    On CPHI since
  • 2
    Certificates
  • 500 - 999
    Employees
Company types
Generics/Biosimilars Manufacturer
Licensee
Primary activities
Pharmaceutical Company (generic finished products)

More Products from Hasco-Lek S.A. (99)

Hasco-Lek S.A. resources (1)

  • Brochure Hasco-Lek License-out List

    HASCO-LEK is a generic production pharmaceutical company located in Poland offering CTD Dossiers (OTC, Rx) and Medical Devices under License & Supply or Distribution agreements and Contract Manufacturing with Technology Transfer or Development options for Pharmaceutical Products and Food Supplements.